Chimeric antigen receptor-T cell therapy for solid tumors require new clinical regimensJǐnjīng Xǔ, Junnian Zheng, Kang Tian et al.|Expert Review of Anticancer Therapy|2017Cited by 22
Obesity Boosts the Tumor Delivery and Anticancer Effects of Liposomal Doxorubicin by an Apolipoprotein E-Mediated MechanismShiyi Xu, Lu Gan, Jianye Li et al.|Molecular Pharmaceutics|2025Cited by 1